...of Investigational New Drug Application for OTX-2002, an...
The Company plans to initiate a Phase 1 clinical trial in the U.S. to evaluate OTX-2002, following FDA clearance. About OTX-2002 OTX-2002 is a first-in-class Omega Epigenomic Controller™ in development fo...